BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28120709)

  • 1. DNA-Damaging Anticancer Drugs - A Perspective for DNA Repair- Oriented Therapy.
    Blasiak J
    Curr Med Chem; 2017; 24(15):1488-1503. PubMed ID: 28120709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tyrosyl-DNA phosphodiesterases: potential targets for cancer treatment].
    Hu Z; Wang HW; An LK
    Yao Xue Xue Bao; 2016 Feb; 51(2):215-25. PubMed ID: 29856574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo analysis of MMC-induced DNA damage and its repair.
    Lee YJ; Park SJ; Ciccone SL; Kim CR; Lee SH
    Carcinogenesis; 2006 Mar; 27(3):446-53. PubMed ID: 16258176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.
    Nitiss KC; Malik M; He X; White SW; Nitiss JL
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):8953-8. PubMed ID: 16751265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.
    Beretta GL; Cossa G; Gatti L; Zunino F; Perego P
    Curr Med Chem; 2010; 17(15):1500-8. PubMed ID: 20166932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excision repair of topoisomerase DNA-protein crosslinks (TOP-DPC).
    Sun Y; Saha S; Wang W; Saha LK; Huang SN; Pommier Y
    DNA Repair (Amst); 2020 May; 89():102837. PubMed ID: 32200233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a putative Tdp1 inhibitor (CD00509) by in vitro and cell-based assays.
    Dean RA; Fam HK; An J; Choi K; Shimizu Y; Jones SJ; Boerkoel CF; Interthal H; Pfeifer TA
    J Biomol Screen; 2014 Dec; 19(10):1372-82. PubMed ID: 25117203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nucleotide excision repair proteins in response to DNA damage induced by topoisomerase II inhibitors.
    Rocha JC; Busatto FF; Guecheva TN; Saffi J
    Mutat Res Rev Mutat Res; 2016; 768():68-77. PubMed ID: 27234564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target.
    Comeaux EQ; van Waardenburg RC
    Drug Metab Rev; 2014 Nov; 46(4):494-507. PubMed ID: 25327705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerases and Anthracyclines: Recent Advances and Perspectives in Anticancer Therapy and Prevention of Cardiotoxicity.
    Mordente A; Meucci E; Martorana GE; Tavian D; Silvestrini A
    Curr Med Chem; 2017; 24(15):1607-1626. PubMed ID: 27978799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Debulking of topoisomerase DNA-protein crosslinks (TOP-DPC) by the proteasome, non-proteasomal and non-proteolytic pathways.
    Sun Y; Saha LK; Saha S; Jo U; Pommier Y
    DNA Repair (Amst); 2020 Oct; 94():102926. PubMed ID: 32674013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cells.
    Fam HK; Walton C; Mitra SA; Chowdhury M; Osborne N; Choi K; Sun G; Wong PC; O'Sullivan MJ; Turashvili G; Aparicio S; Triche TJ; Bond M; Pallen CJ; Boerkoel CF
    Mol Cancer Res; 2013 Oct; 11(10):1179-92. PubMed ID: 23913164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosyl-DNA phosphodiesterase (Tdp1) (3'-phosphotyrosyl DNA phosphodiesterase).
    Raymond AC; Burgin AB
    Methods Enzymol; 2006; 409():511-24. PubMed ID: 16793421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection and repair of 3'-blocking DNA ends by glaikit (gkt) encoding Drosophila tyrosyl-DNA phosphodiesterase 1 (TDP1).
    Guo D; Dexheimer TS; Pommier Y; Nash HA
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15816-20. PubMed ID: 25331878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors.
    Al Abo M; Sasanuma H; Liu X; Rajapakse VN; Huang SY; Kiselev E; Takeda S; Plunkett W; Pommier Y
    Mol Cancer Ther; 2017 Nov; 16(11):2543-2551. PubMed ID: 28802254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
    Clingen PH; Arlett CF; Hartley JA; Parris CN
    Exp Cell Res; 2007 Feb; 313(4):753-60. PubMed ID: 17188678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of TDP1 in the repair of formaldehyde-induced DNA-protein cross-links in chicken DT40 cells.
    Nakano T; Shoulkamy MI; Tsuda M; Sasanuma H; Hirota K; Takata M; Masunaga SI; Takeda S; Ide H; Bessho T; Tano K
    PLoS One; 2020; 15(6):e0234859. PubMed ID: 32589683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Base excision repair proteins are required for integrin-mediated suppression of bleomycin-induced DNA breakage in murine lung endothelial cells.
    Rose JL; Reeves KC; Likhotvorik RI; Hoyt DG
    J Pharmacol Exp Ther; 2007 Apr; 321(1):318-26. PubMed ID: 17202402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosyl-DNA phosphodiesterases: rescuing the genome from the risks of relaxation.
    Kawale AS; Povirk LF
    Nucleic Acids Res; 2018 Jan; 46(2):520-537. PubMed ID: 29216365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.
    Laev SS; Salakhutdinov NF; Lavrik OI
    Bioorg Med Chem; 2016 Nov; 24(21):5017-5027. PubMed ID: 27687971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.